These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of cholesterol on the structure of membrane-attached cytochrome P450 3A4. Navrátilová V; Paloncýová M; Kajšová M; Berka K; Otyepka M J Chem Inf Model; 2015 Mar; 55(3):628-35. PubMed ID: 25654496 [TBL] [Abstract][Full Text] [Related]
4. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations. Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162 [TBL] [Abstract][Full Text] [Related]
5. Small-angle scattering determination of the shape and localization of human cytochrome P450 embedded in a phospholipid nanodisc environment. Skar-Gislinge N; Kynde SA; Denisov IG; Ye X; Lenov I; Sligar SG; Arleth L Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2412-21. PubMed ID: 26627649 [TBL] [Abstract][Full Text] [Related]
6. Lipid specificity of the membrane binding domain of coagulation factor X. Muller MP; Wang Y; Morrissey JH; Tajkhorshid E J Thromb Haemost; 2017 Oct; 15(10):2005-2016. PubMed ID: 28782177 [TBL] [Abstract][Full Text] [Related]
7. A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes. Lonsdale R; Rouse SL; Sansom MS; Mulholland AJ PLoS Comput Biol; 2014 Jul; 10(7):e1003714. PubMed ID: 25033460 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Sevrioukova IF; Poulos TL Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486 [TBL] [Abstract][Full Text] [Related]
9. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery. Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037 [TBL] [Abstract][Full Text] [Related]
10. Membrane Interactions, Ligand-Dependent Dynamics, and Stability of Cytochrome P4503A4 in Lipid Nanodiscs. Treuheit NA; Redhair M; Kwon H; McClary WD; Guttman M; Sumida JP; Atkins WM Biochemistry; 2016 Feb; 55(7):1058-69. PubMed ID: 26814638 [TBL] [Abstract][Full Text] [Related]
11. Effect of Lipid Charge on Membrane Immersion of Cytochrome P450 3A4. Navrátilová V; Paloncýová M; Berka K; Otyepka M J Phys Chem B; 2016 Nov; 120(43):11205-11213. PubMed ID: 27723344 [TBL] [Abstract][Full Text] [Related]
12. Identification of a less toxic vinca alkaloid derivative for use as a chemotherapeutic agent, based on in silico structural insights and metabolic interactions with CYP3A4 and CYP3A5. Saba N; Seal A J Mol Model; 2018 Mar; 24(4):82. PubMed ID: 29502215 [TBL] [Abstract][Full Text] [Related]
13. Conformational Response of N-Terminally Truncated Cytochrome P450 3A4 to Ligand Binding in Solution. Chuo SW; Liou SH; Wang LP; Britt RD; Poulos TL; Sevrioukova IF; Goodin DB Biochemistry; 2019 Sep; 58(37):3903-3910. PubMed ID: 31456404 [TBL] [Abstract][Full Text] [Related]
14. Structural features and dynamic investigations of the membrane-bound cytochrome P450 17A1. Cui YL; Xue Q; Zheng QC; Zhang JL; Kong CP; Fan JR; Zhang HX Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2013-21. PubMed ID: 26025587 [TBL] [Abstract][Full Text] [Related]
15. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD). Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772 [TBL] [Abstract][Full Text] [Related]
16. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen. Shahrokh K; Cheatham TE; Yost GS Biochim Biophys Acta; 2012 Oct; 1820(10):1605-17. PubMed ID: 22677141 [TBL] [Abstract][Full Text] [Related]
18. Binding Specificity Determines the Cytochrome P450 3A4 Mediated Enantioselective Metabolism of Metconazole. Zhuang S; Zhang L; Zhan T; Lu L; Zhao L; Wang H; Morrone JA; Liu W; Zhou R J Phys Chem B; 2018 Jan; 122(3):1176-1184. PubMed ID: 29310431 [TBL] [Abstract][Full Text] [Related]
19. Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium. Davydov DR; Sineva EV; Sistla S; Davydova NY; Frank DJ; Sligar SG; Halpert JR Biochim Biophys Acta; 2010 Mar; 1797(3):378-90. PubMed ID: 20026040 [TBL] [Abstract][Full Text] [Related]
20. Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4. Hsu MH; Johnson EF J Biol Chem; 2019 May; 294(20):8015-8022. PubMed ID: 30926609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]